Sun Pharma NJ Plant Passes FDA Review After Warning
The U.S. Food and Drug Administration last week approved Sun Pharmaceutical Industries Ltd.'s corrective actions at a Cranbury, N.J., manufacturing plant cited last year for quality control violations that included imploding...To view the full article, register now.
Already a subscriber? Click here to view full article